GLP1 receptor agonists: from antihyperglycaemic to cardiovascular drugs

Darren K. McGuire; Neha J. Pagidipati

doi:10.1016/S2213-8587(21)00212-6

GLP1 receptor agonists: from antihyperglycaemic to cardiovascular drugs

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	640-641
Number of pages	2
Journal	The Lancet Diabetes and Endocrinology
Volume	9
Issue number	10
DOIs	https://doi.org/10.1016/S2213-8587(21)00212-6
State	Published - Oct 2021

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Endocrinology

Access to Document

10.1016/S2213-8587(21)00212-6

Cite this

@article{74f962afe35148ddb24726b2032b0c6a,

title = "GLP1 receptor agonists: from antihyperglycaemic to cardiovascular drugs",

author = "McGuire, {Darren K.} and Pagidipati, {Neha J.}",

year = "2021",

month = oct,

doi = "10.1016/S2213-8587(21)00212-6",

language = "English (US)",

volume = "9",

pages = "640--641",

journal = "The Lancet Diabetes and Endocrinology",

issn = "2213-8587",

publisher = "Elsevier BV",

number = "10",

}

TY - JOUR

T1 - GLP1 receptor agonists

T2 - from antihyperglycaemic to cardiovascular drugs

AU - McGuire, Darren K.

AU - Pagidipati, Neha J.

PY - 2021/10

Y1 - 2021/10

UR - http://www.scopus.com/inward/record.url?scp=85114770707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85114770707&partnerID=8YFLogxK

U2 - 10.1016/S2213-8587(21)00212-6

DO - 10.1016/S2213-8587(21)00212-6

M3 - Comment/debate

C2 - 34425084

AN - SCOPUS:85114770707

SN - 2213-8587

VL - 9

SP - 640

EP - 641

JO - The Lancet Diabetes and Endocrinology

JF - The Lancet Diabetes and Endocrinology

IS - 10

ER -

GLP1 receptor agonists: from antihyperglycaemic to cardiovascular drugs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this